1
/
of
1
Elabscience
SKU:PKSH034049
Recombinant Human HLA-A*0201 HPV16 E7 complex Protein (C-10His)
Recombinant Human HLA-A*0201 HPV16 E7 complex Protein (C-10His)
Regular price
$155.00 USD
Regular price
Sale price
$155.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Human HLA-A*0201 HPV16 E7 Complex Protein (C-10HIS), a cutting-edge product meticulously designed to cater to the needs of the scientific community. This protein complex, derived from the human leukocyte antigen (HLA) A*0201 and the human papillomavirus (HPV) type 16 E7 protein, offers an unparalleled opportunity for in-depth research and analysis.
Crafted with utmost precision, this recombinant protein complex showcases the fusion of HLA-A*0201 and HPV16 E7, resulting in a novel entity that holds immense potential for various scientific applications. The inclusion of a C-terminal histidine (HIS) tag further enhances the versatility and ease of use of this product.
The Recombinant Human HLA-A*0201 HPV16 E7 Complex Protein (C-10HIS) boasts exceptional purity and stability, ensuring reliable and reproducible results in a wide range of experimental settings. Its high affinity for HPV16 E7 epitopes enables precise and accurate binding, facilitating comprehensive investigations into the interactions between HLA-A*0201 and HPV16 E7.
This product is meticulously manufactured using state-of-the-art techniques, guaranteeing the highest standards of quality and consistency. Rigorous quality control measures are implemented throughout the production process to ensure the utmost purity, integrity, and functionality of the Recombinant Human HLA-A*0201 HPV16 E7 Complex Protein (C-10HIS).
Researchers and scientists can harness the immense potential of this protein complex for a myriad of applications, including but not limited to immunological studies, vaccine development, and therapeutic research. Its versatility and reliability make it an indispensable tool in unraveling the intricate mechanisms underlying HPV16 E7-mediated immune responses.
In conclusion, the Recombinant Human HLA-A*0201 HPV16 E7 Complex Protein (C-10HIS) stands as a pinnacle of scientific innovation, offering an invaluable resource for researchers seeking to delve into the complexities of HLA-A*0201 and HPV16 E7 interactions. With its exceptional purity, stability, and functionality, this product is poised to revolutionize the field of HPV research and contribute to advancements in immunology and therapeutic interventions.
Crafted with utmost precision, this recombinant protein complex showcases the fusion of HLA-A*0201 and HPV16 E7, resulting in a novel entity that holds immense potential for various scientific applications. The inclusion of a C-terminal histidine (HIS) tag further enhances the versatility and ease of use of this product.
The Recombinant Human HLA-A*0201 HPV16 E7 Complex Protein (C-10HIS) boasts exceptional purity and stability, ensuring reliable and reproducible results in a wide range of experimental settings. Its high affinity for HPV16 E7 epitopes enables precise and accurate binding, facilitating comprehensive investigations into the interactions between HLA-A*0201 and HPV16 E7.
This product is meticulously manufactured using state-of-the-art techniques, guaranteeing the highest standards of quality and consistency. Rigorous quality control measures are implemented throughout the production process to ensure the utmost purity, integrity, and functionality of the Recombinant Human HLA-A*0201 HPV16 E7 Complex Protein (C-10HIS).
Researchers and scientists can harness the immense potential of this protein complex for a myriad of applications, including but not limited to immunological studies, vaccine development, and therapeutic research. Its versatility and reliability make it an indispensable tool in unraveling the intricate mechanisms underlying HPV16 E7-mediated immune responses.
In conclusion, the Recombinant Human HLA-A*0201 HPV16 E7 Complex Protein (C-10HIS) stands as a pinnacle of scientific innovation, offering an invaluable resource for researchers seeking to delve into the complexities of HLA-A*0201 and HPV16 E7 interactions. With its exceptional purity, stability, and functionality, this product is poised to revolutionize the field of HPV research and contribute to advancements in immunology and therapeutic interventions.
Share
